Icecure Medical Ltd (ICCM)

May 30, 2025

H.C. Wainwright maintains Buy on IceCure Medical, target at $2.50 By Investing.com - Investing.com South Africa

May 30, 2025

May 30, 2025

H.C. Wainwright maintains Buy on IceCure Medical, target at $2.50 - Investing.com Australia

May 30, 2025

May 30, 2025

IceCure Medical’s (ICCM) Buy Rating Reaffirmed at HC Wainwright - Defense World

May 30, 2025

May 29, 2025

Icecure Medical Ltd (ICCM) Q1 2025 Earnings Call Highlights: Strategic Advances and Market ... - Yahoo Finance

May 29, 2025

May 29, 2025

Icecure Medical Ltd (ICCM) Q1 2025 Earnings Call Highlights: Strategic Advances and Market Challenges - GuruFocus

May 29, 2025

May 29, 2025

ICCM: HC Wainwright & Co. Reiterates Buy Rating with $2.50 Price Target | ICCM Stock News - GuruFocus

May 29, 2025

May 29, 2025

IceCure Medical Ltd (NASDAQ:ICCM) Q1 2025 Earnings Call Transcript - Insider Monkey

May 29, 2025

May 29, 2025

IceCure Medical outlines post-market study plan for ProSense amid FDA engagement and prepares for US commercial launch - MSN

May 29, 2025

May 29, 2025

IceCure Medical reports 2% revenue drop in Q1 2025 - Medical Buyer

May 29, 2025

May 28, 2025

IceCure Medical Reports Q1 2025 Financial Results - TipRanks

May 28, 2025

May 28, 2025

IceCure Medical’s Earnings Call: Optimism Amid Challenges - TipRanks

May 28, 2025

May 28, 2025

Transcript : IceCure Medical Ltd, Q1 2025 Earnings Call, May 28, 2025 - marketscreener.com

May 28, 2025

May 28, 2025

Icecure Medical Ltd reports results for the quarter ended March 31Earnings Summary - TradingView

May 28, 2025

May 28, 2025

IceCure (ICCM) Q1 2025 Earnings Call Transcript - The Globe and Mail

May 28, 2025

May 28, 2025

IceCure (ICCM) Q1 2025 Earnings Call Transcript - The Motley Fool

May 28, 2025

May 28, 2025

IceCure Medical Ltd Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 28, 2025

May 28, 2025

ICECURE MEDICAL Earnings Results: $ICCM Reports Quarterly Earnings - Nasdaq

May 28, 2025

May 28, 2025

IceCure Medical Reports First Quarter 2025 Financial Results - PR Newswire

May 28, 2025

May 27, 2025

Icecure Medical Ltd (ICCM) Q1 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus

May 27, 2025

May 24, 2025

IceCure to Report First Quarter 2025 Financial & Operational Results on May 28, 2025 - Nasdaq

May 24, 2025

May 21, 2025

IceCure Medical Secures $2 Million Bridge Loan from Epoch - TipRanks

May 21, 2025

May 21, 2025

IceCure Medical Earnings: Cryoablation Pioneer Reports Q1 2025 Results May 28 - Stock Titan

May 21, 2025

May 20, 2025

IceCure Medical (ICCM) Expected to Announce Earnings on Tuesday - Defense World

May 20, 2025

May 15, 2025

IceCure Medical’s Shareholders Approve Key Agenda Items at Special Meeting - TipRanks

May 15, 2025

May 11, 2025

Upcoming FDA Advisory Panel for IceCure's ProSense® Marketing Authorization Receives Large Number of Public Comments from Stakeholders - marketscreener.com

May 11, 2025

May 09, 2025

FY2025 EPS Estimates for IceCure Medical Boosted by Analyst - Defense World

May 09, 2025

May 06, 2025

IceCure Receives High Level of Interest from Breast Surgeons at - GuruFocus

May 06, 2025

May 06, 2025

IceCure Receives High Level of Interest from Breast Surgeons at ASBrS 2025 Annual Meeting Following Recent Positive FDA Development on ProSense® Cryoablation - PR Newswire

May 06, 2025

May 05, 2025

IceCure Medical Ltd (NASDAQ:ICCM) Shares Acquired by Geode Capital Management LLC - Defense World

May 05, 2025

May 02, 2025

IceCure Medical Takes Next Major Initiative as it Prepares to Accelerate the Commercialization of ProSense in U.S. and Canada: Appoints VP of Sales, North America - Barchart.com

May 02, 2025

Apr 30, 2025

IceCure Medical reports on FDA meeting for ProSense Cryoablation - TipRanks

Apr 30, 2025

Apr 30, 2025

ICCM Advances ProSense Approval with FDA Interface | ICCM Stock News - GuruFocus

Apr 30, 2025

Apr 30, 2025

IceCure Announces Positive FDA Development: Understanding on Pat - GuruFocus

Apr 30, 2025

Apr 30, 2025

IceCure Announces Positive FDA Development: Understanding on Path Forward for Marketing Authorization of ProSense® Cryoablation in Women 70+ with Early-Stage Breast Cancer - PR Newswire

Apr 30, 2025

Apr 28, 2025

IceCure Exhibits ProSense® & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium - GuruFocus

Apr 28, 2025

Apr 26, 2025

IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogenic Pump for its Next-Generation Cryoablation Systems - marketscreener.com

Apr 26, 2025

Apr 24, 2025

Comparing Biotricity (NASDAQ:BTCY) and IceCure Medical (NASDAQ:ICCM) - Defense World

Apr 24, 2025

Apr 22, 2025

IceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation - StreetInsider

Apr 22, 2025

Apr 22, 2025

IceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation | ICCM Stock News - GuruFocus

Apr 22, 2025

Apr 22, 2025

IceCure Medical (NASDAQ:ICCM) Shares Down 3.1% – Time to Sell? - Defense World

Apr 22, 2025

Apr 10, 2025

IceCure Medical Announces Special Shareholder Meeting for May 2025 - TipRanks

Apr 10, 2025

Mar 31, 2025

FY2027 EPS Estimates for IceCure Medical Reduced by Analyst - Defense World

Mar 31, 2025

Mar 30, 2025

IceCure Medical (NASDAQ:ICCM) Earns Buy Rating from HC Wainwright - Defense World

Mar 30, 2025